Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
0.8056
0.00 (0.00%)
Oct 26, 2026, 9:50 AM EDT - Market open
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $30.43 million as of October 26, 2026. It is the 33,801st most valuable company in the world and the 4,963rd biggest in the United States. Its market cap has decreased by 71.94% in one year.
Market Cap
30.43M
Enterprise Value
-52.51M
1-Year Change
-71.94%
Global Rank
Country Rank
#4,963 United States
Category
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $30.43M, a decrease of -94.59%. That is a compound annual growth rate of -65.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 30.43M | -49.97% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IRulya Therapeutics | 33.64M |
| Celularity | 31.73M |
| Evaxion | 31.36M |
| Impact BioMedical | 30.76M |
| Filana Therapeutics | 30.70M |
| Aardvark Therapeutics | 30.42M |
| BriaCell Therapeutics | 30.22M |
| TransCode Therapeutics | 29.97M |